The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

News Summary: 2018 predictions, reovirus immunotherapy, alcohol and cancer

July 17, 2018
News Summary: 2018 predictions, reovirus immunotherapy, alcohol and cancer
precision medicine 2018
Credit: AACR

Experts Forecast Cancer Research and Treatment Advances in 2018

The AACR asked experts in the fields of immunotherapy, precision medicine, and prevention and disparities research where the cancer research community is headed next and what major accomplishments we might expect in 2018 to take us closer to conquering cancer.


Credit: Cancer Research UK

EACR Board member Caroline Dive honoured by the Queen in New Year’s Honours 2018

The New Year’s Honours list is a list of awards made by the UK government and presented by the Queen. The honours system recognises people who have made achievements in public life and committed themselves to making life better for other people and being outstanding at what they do.

In the 2018 New Year’s Honours list EACR Board member Professor Caroline Dive has been named a Commander of the Order of the British Empire (CBE). Professor Dive is a senior group leader at the Cancer Research UK Manchester Institute, and her team works alongside the Christie Hospital in developing ‘liquid biopsies’ to hunt cancer cells that have broken free from tumours and are circulating in the bloodstream.


Credit: NIAID

Virus could treat brain tumours by boosting immune system

A virus injected directly into the bloodstream could be used to treat people with aggressive brain tumours, a major new study published in the journal Science Translational Medicine reports.

Researchers at the University of Leeds and The Institute of Cancer Research, London have found that the reovirus could cross the blood-brain barrier to reach tumours, where it replicates and kills the cancer cells. The virus was able to ‘switch-on’ the body’s own defence systems to attack the brain tumours in humans, and to boost the effectiveness of the current wave of exciting immune therapy drugs in mice.

The study authors believe reovirus therapy could be used in conjunction with other cancer therapies to make them more potent – and clinical trials are currently underway. Because the virus infects cancer cells and leaves healthy cells alone, patients receiving the treatment reported only mild flu-like side effects.


Credit: Cancer Research UK

Alcohol and cancer: how alcohol damages DNA inside cells

In honour of the New Year, Cancer Research UK have published a blog post on the process of how alcohol can cause cancer. It focuses in particular on a new paper published in the journal Nature,  ‘Alcohol-derived and endogenous aldehydes damage chromosomes and mutate stem cells.’

Alcohol is broken down via a strict process and converted into energy. And it’s acetaldehyde, at the centre of this chain, that’s the weakest link. If acetaldehyde isn’t broken down further it builds up in cells, where it damages DNA in a way that could cause cancer.

 

Post Views: 2
Tags: brain tumourEACR Boardnews summary

Related Posts

VIDEO | Rapid and accurate pan-cancer subtyping using RNA-sequencing

VIDEO | Rapid and accurate pan-cancer subtyping using RNA-sequencing

July 23, 2026

Click above to watch On 20 July 2026, the EACR hosted a webinar in collaboration with Oxford Nanopore Technologies, one of our valued EACR Industry Partners....

Scientific Highlights from ‘Cancer Genomics, Multiomics and Computational Biology’ 2026

Scientific Highlights from ‘Cancer Genomics, Multiomics and Computational Biology’ 2026

July 15, 2026

The EACR's Cancer Genomics, Multiomics and Computational Biology conference (Essen, 12–14 May 2026) centred on integrating high-resolution genomic and multi-omic data with advanced computational and AI-driven...

EACR 2026 Annual Congress in review: “Exceptional networking opportunities and invaluable knowledge sharing”

EACR 2026 Annual Congress in review: “Exceptional networking opportunities and invaluable knowledge sharing”

July 1, 2026

We were delighted to welcome the cancer research community to Budapest, Hungary for the EACR Annual Congress 2026: Innovative Cancer Science between 08 - 11 June...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

Advertisement Advertisement Advertisement
ADVERTISEMENT

RECENT POSTS

EACR 2026 Congress Travel Grant recipients share their experiences
Career

EACR 2026 Congress Travel Grant recipients share their experiences

July 29, 2026
“This access gave me a new perspective on how research can be done”- Katarzyna Wierzbicka’s Travel Fellowship
Career

“This access gave me a new perspective on how research can be done”- Katarzyna Wierzbicka’s Travel Fellowship

July 28, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR